ISDA

Deposition Date 2008-08-08

Release Date 2008-10-14

Last Version Date 2024-05-01

Entry Detail

PDB ID:

2W05

Keywords:

TRANSFERASE

Title:

Structure of CDK2 in complex with an imidazolyl pyrimidine, compound 5b

Biological Source:

Source Organism:

HOMO SAPIENS (Taxon ID: 9606)

Host Organism:

SPODOPTERA FRUGIPERDA

Method Details:

Experimental Method:

X-RAY DIFFRACTION

Resolution:

1.90 Å

R-Value Free:

0.29

R-Value Work:

0.22

Space Group:

P 21 21 21

Download Validation Report

Macromolecular Entities

Protein Blast

Polymer Type:polypeptide(L)
Molecule:CELL DIVISION PROTEIN KINASE 2
Gene (Uniprot):CDK2
Chain IDs:A
Chain Length:298
Number of Molecules:1
Biological Source:HOMO SAPIENS

UniProt ID:P24941 Pfam ID:PF00069 EC:2.7.11.22

Ligand Molecules

FRT

Primary Citation

Imidazoles: Sar and Development of a Potent Class of Cyclin-Dependent Kinase Inhibitors.

Anderson, M, Andrews, D.M, Barker, A.J, Brassington, C.A, Breed, J, Byth, K.F, Culshaw, J.D, Finlay, M.R, Fisher, E, Mcmiken, H.H, Green, C.P, Heaton, D.W, Nash, I.A, Newcombe, N.J, Oakes, S.E, Pauptit, R.A, Roberts, A, Stanway, J.J, Thomas, A.P, Tucker, J.A, Walker, M, Weir, H.M.Show

Bioorg.Med.Chem.Lett. 18 5487 ? (2008)

PMID: 18815031 DOI: 10.1016/J.BMCL.2008.09.024

Abstact

An imidazole series of cyclin-dependent kinase (CDK) inhibitors has been developed. Protein inhibitor structure determination has provided an understanding of the emerging structure activity trends for the imidazole series. The introduction of a methyl sulfone at the aniline terminus led to a more orally bioavailable CDK inhibitor that was progressed into clinical development.

Legend

Protein

Chemical

Disease

Primary Citation of related structures